eEF2K activity determines synergy to PI3K and MEK inhibitors in combination in cancer cells
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
To understand the mechanisms involved in synergy to PI3Ki + MEKi treatment, we performed a global phosphoproteomics analysis in 3 different cancer cell lines treated with a MEK inhibitor (Trametinib) and a PI3K inhibitor (Pictilisib) at 500 nM individually or in combination for one hour.
创建时间：
2022-04-25
